Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.

Abstract

Circulation. 2017;136:602–604. DOI: 10.1161/CIRCULATIONAHA.117.028745 602 Prasugrel or ticagrelor is recommended in patients with ST-segment–elevation myocardial infarction (STEMI). Patients with diabetes mellitus are characterized by enhanced platelet reactivity (PR) and a reduced response to oral antiplatelet agents.1 The RESET 2D trial (Prasugrel vs… (More)
DOI: 10.1161/CIRCULATIONAHA.117.028745

Topics

  • Presentations referencing similar topics